Merck & CO INC MERCK & CO ORD (CDI)
Merck & CO INC MERCK & CO ORD (CD.../ US58933Y1055 /
0QAH
24/05/2024 16:45:29
|
Chg.
-
|
Volume |
Bid09:00:28 |
Ask10:02:31 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
130.4000USD
|
-
|
7,774 Turnover: - |
123.4000Bid Size: 150 |
134.6000Ask Size: 150 |
326 bill.USD |
2.30% |
919.36 |
Business description
Today’s Merck is a global healthcare leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through its prescription medicines, vaccines, biologic therapies and animal health products, the company works with customers and operate in more than 140 countries to deliver innovative health solutions. Merck also demonstrates its commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
Management board & Supervisory board
CEO |
Robert M. Davis |
Management board |
Caroline Litchfield, Sanat Chattopadhyay, Richard R. DeLuca, Jr., Cristal N. Downing, Michael A. Klobuchar, Jannie Oosthuizen, Joseph Romanelli, Dave Williams, Jennifer Zachary, Dean Y. Li, M.D., Ph.D., Chirfi Guindo, Betty Larson |
Supervisory board |
Robert M. Davis, Thomas H. Glocer, Risa J. Lavizzo-Mourey, M.D., Stephen L. Mayo, Ph.D., Paul B. Rothman, M.D., Patricia F. Russo, Christine E. Seidman, M.D., Inge G. Thulin, Kathy J. Warden, Peter C. Wendell, Mary Ellen Coe, Pamela J. Craig, Douglas M. Baker |
Company data
Name: |
Merck & Co. Inc. |
Address: |
126 East Lincoln Avenue,Rahway, NJ 07065 USA |
Phone: |
+1-908-740-4000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.merck.com |
Industry: |
Healthcare |
Sector: |
Pharmaceutical Industry |
Sub sector: |
Pharmaceuticals |
End of financial year: |
31/12 |
Free Float: |
83.84% |
IPO date: |
- |
Company calendar
CW 31 | 30/07/2024
Interim Report 2nd Quarter/6 Months
|
CW 44 | 31/10/2024
Interim Report 3rd Quarter/9 Months
|